Suppositories Buscopan rectal 10 mg, # 10

Buscopan Rectal suppositories 10mg No. 10

Name ENG

BUSCOPAN

Clinical and pharmacological group

M-cholinergic receptor blocker

ATX code

Butylscopolamine

Dosage

10mg

Structure

1 suppository contains:

.Active substances: hyoscine-N-butyl bromide 10 mg

.Auxiliary substances: purified water

fat W45 solid.

Indications

Renal colic, biliary colic, spastic dyskinesia of the biliary tract and gall bladder, cholecystitis, intestinal colic, pylorospasm, gastric ulcer and duodenal ulcer in the acute phase (as part of complex therapy), algodismenorrhea.

Contraindications

Myasthenia gravis, megacolon.

Hypersensitivity to hyoscine butyl bromide or any other component of the drug.

Children under 6 years old.

INN / Active ingredient

Hyoscine butyl bromide

Storage conditions and periods

In a dry place, at a temperature not exceeding 25 degrees.

Expiration date: 5 years

Specifications

Category

Laxatives

Scope of the drug

General

Release form

Suppositories

Manufacturer country

Italy

Package quantity, pcs

ten

Scope of application

Gastroenterology

Minimum age from

6 years

Way of introduction

Rectally

Vacation conditions

Without recipe

Brand name

Boehringer ingelheim

The amount of the dosage form in the primary package

5 pieces.

Primary packaging type

Cell-free contoured packaging (strip)

Type of consumer packaging

Pack of cardboard

Pharmaco-therapeutic group

M-holinoblokator

Anatomical and therapeutic characteristics

A03BB01 Hyoscine butyl bromide

Dosage form

Rectal suppositories

Expiration date in days

1826

Dosage (volume) of the substance in the preparation

10 mg hyoscine butyl bromide

Package weight, g

ten

Mode of application

:

Rectally (suppositories), unless otherwise prescribed, for adults and children over 6 years of age - 1–2 suppositories.

3 times a day.

< br> Suppositories should be removed from the shell and inserted into the rectum with the pointed end forward. < br> The duration of use is determined by the doctor.